Pubblicazioni

Modulating undruggable targets to overcome cancer therapy resistance

2022 - DRUG RESISTANCE UPDATES

Passirani, C.; Vessieres, A.; La Regina, G.; Link, W.; Silvestri, R.

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

2021 - FRONTIERS IN IMMUNOLOGY

D'Amico, Silvia; D'Alicandro, Valerio; Compagnone, Mirco; Tempora, Patrizia; Guida, Giusy; Romania, Paolo; Lucarini, Valeria; Melaiu, Ombretta; Falco, Michela; Algeri, Mattia; Pende, Daniela; Cifaldi, Loredana; Fruci, Doriana

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

2021 - FRONTIERS IN IMMUNOLOGY

Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences

2019 - JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Cirone, M.; Gilardini Montani, M. S.; Granato, M.; Garufi, A.; Faggioni, A.; D'Orazi, G.

Metabolite profiling of ascidian Styela plicata using LCâMS with multivariate statistical analysis and their antitumor activity

2017 - JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Palanisamy, S. K.; Trisciuoglio, D.; Zwergel, C.; Del Bufalo, D.; Mai, A.

Targeting nuclear transporters in cancer: Diagnostic, prognostic and therapeutic potential

2016 - IUBMB LIFE

Stelma, Tamara; Chi, Alicia; Van Der Watt, Pauline J.; Verrico, Annalisa; Lavia, Patrizia; Leaner, Virna D.

Targeting GLI factors to inhibit the Hedgehog pathway

2015 - TRENDS IN PHARMACOLOGICAL SCIENCES

Infante, Paola; Alfonsi, Romina; Botta, Bruno; Mori, Mattia; Di Marcotullio, Lucia